The improvement of insulin resistance and the antioxidant capacity in type 2 diabetes mellitus rats with whiteleg shrimp shell powder (Litopenaeus vannamei) by Ahriyasna, Risya et al.
Potravinarstvo Slovak Journal of Food Sciences 




Potravinarstvo Slovak Journal of Food Sciences 
vol. 15, 2021, p. 703-711 
https://doi.org/10.5219/1684 
Received: 14 June 2021. Accepted: 25. August 2021. 
Available online: 28 September 2021 at www.potravinarstvo.com 
© 2021 Potravinarstvo Slovak Journal of Food Sciences, License: CC BY 4.0  
ISSN 1337-0960 (online)  
 
THE IMPROVEMENT OF INSULIN RESISTANCE AND THE ANTIOXIDANT 
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SHELL POWDER (LITOPENAEUS VANNAMEI) 
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ABSTRACT 
As estimated having an increased incidence of about 50% until 2040, the diabetic condition could be augmented primarily 
from astaxanthin contained in carotenoids. This research examines and compares the influence of WSSP and AST 
complement on Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) level and Total Antioxidant Capacity 
(TAC) induced high-fat diet streptozotocin (HFD-STZ) in T2DM rats. WSSP 0.89gr/200gr/d (X1) and 1.77gr/200gr/d (X2) 
groups; and AST supplement 0.09mg/200gr/d (X3) groups were compared with both of positive (K1) and negative (K2) 
groups. The treatments were administered orally for 21 days to 25 Wistar rats which each group consisted of 5 rats. 
HOMA-IR and TAC levels were measured by ELISA and ABTs method respectively. TAC levels significantly increased in 
treatment groups than K1 group (p = 0.008). The increase in the TAC level of the X2 group was greater than the X1 group 
(p = 0.017). HOMA IR levels were significantly lower in treatment groups than K1 group (p = 0.009). X2 group had a 
greater decrease in HOMA IR levels compared to X1 (p = 0.016). In consequence, the research findings show a utilitarian 
effect of WSSP in increasing TAC and decreasing the HOMA-IR index. 
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INTRODUCTION 
 Type 2 Diabetes Mellitus (T2DM) is a non-
communicable disease that remains to be a global issue in 
which the incidence continues to increase every year. In 
2015, the International Diabetic Federation (IDF) 
estimated that the number of people with diabetes will 
reach 415 million people with an estimation that will 
increase to 642 million people in 2040 (IDF, 2015). The 
occurrence of diabetes in Indonesia reached 10 million in 
2015, and it continuously increases each year for 4-6% of 
the world population until 2020, including Gestational 
Diabetes Mellitus (GDM) (IDF, 2017; Primal, Putri and 
Meiriza, 2021). Type 2 Diabetes Mellitus (T2DM) is a 
metabolic disorder characterized by hyperglycemia due to 
impaired metabolism of nutrients, as a result of decreased 
secretion and sensitivity toward insulin known as insulin 
resistance. Abnormality of metabolic nutrients induces 
increasing oxidative stress due to an imbalance between 
the levels of Reactive Oxygen Species (ROS) and Total 
Antioxidant Capacity (TAC) in the body (Nolan, Damm 
and Prentki, 2011).  
 A decrease in TAC in the body results in damage of 
insulin receptor cell insulin resistance by activating several 
enzymes. The increase in circulating fatty acids in the liver 
and muscle results in increased activity of Protein Kinase 
C (PKC) followed by a disruption of phosphorylation in 
Insulin Receptor Substrate (IRS-1 and IRS-2) as an 
indication of liver and muscle insulin resistance. 
Circulating fatty acids can also activate the Hypoxia-
Inducible Factor-1 (HIF-1) gene which will increase Jun 
N-terminal Kinase (JNK) and IkB Kinase (IKK) activity 
which will lead to insulin resistance to adipose tissue.  The 
condition of chronic insulin resistance causes 
glucolipotoxicity to pancreatic β cells which results in a 
decrease in insulin secretion and an increase in blood 
glucose levels which is known as T2DM (Sears and 
Perry, 2014; Samuel and Shulman, 2012; Kupsal et al, 
2015).  
 The decrease of TAC in T2DM exacerbates insulin 
resistance which can be measured by the Homeostasis 
Model Assessment of Insulin Resistance (HOMA-IR). 
This method illustrates the feedback response between 
insulin secretion by pancreatic β cells with glucose uptake 
from the circulation by insulin receptor cells into glucose 
target cells (Antunes et al., 2016). Traditional medicine 
derived from nature is currently one of the most popular 
medical techniques. Whiteleg shrimp shells are part of 
unused shrimps in the shrimp processing industry, 
especially in Indonesia. The benefits of shrimp shells for 
health have not been widely known, especially for T2DM. 
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Whiteleg shrimp shells contain several bioactive 
components such as AST of 101.7 ±11.2 µg / gr which is 
the main antioxidant in Whiteleg shrimp shells. The other 
bioactive components are chitosan, Mono Unsaturated 
Fatty Acid (MUFA), Poly Unsaturated Fatty Acid (PUFA), 
vitamin E, vitamin A, and calcium (Hue et al, 2008; 
Nair et al, 2017; Cahú et al, 2012; Suptijah, Jacoeb and 
Deviyanti, 2012). 
 Each bioactive component that is also found in WSSP 
content has been investigated for its protective role in 
T2DM. The protective mechanisms used are suppressing 
oxidative stress, suppressing the process of 
gluconeogenesis in the liver, increasing uptake of glucose 
into the tissue, and stimulating insulin secretion in 
pancreatic β cells (Ambati et al, 2014; Liu, Chang and 
Chiang, 2010; Hodgkin, Hills and Squires, 2008). 
Astaxanthin is an important component of WSSP and pure 
AST from many sources that have been studied for its 
protective role in T2DM and obese animal model (Sila et 
al, 2015; Li et al, 2016; Chan, Pen and Yin, 2012). The 
treatment of shrimp extract oil is proven to be protective as 
indicated by improvement of HOMA-IR in HFD-STZ 
induced. Our study used WSSP to avoid decreasing levels 
of an active component during extraction. This study has 
never been done before; therefore, it is expected that this 
study can provide knowledge to the community that the 
whiteleg shrimp shell is the potential to improve T2DM 
conditions and it is expected to produce a product that can 




 The research hypothesis hinged on the assumptions that 
the whiteleg shrimp shell powder (Litopenaeus Vannamei) 
could be positively improving the insulin resistance and 
antioxidant level of T2DM rats. As an object of the in vivo 
study in Wistar strain rats, WSSP in different doses and 
AST supplement has been approved as an improvement of 
total antioxidant capacity and insulin resistance. 
 
MATERIAL AND METHODOLOGY 
 
Samples 
 The drying process of shrimp shells using the freeze-
drying method was aimed at maintaining the quality and 
quantity of bioactive substances found in shrimp shells 
(Shofian et al., 2011). The WSSP processing referred to 
the previous manufacturing technique which is suitable for 
maintaining the bioactive component in WSSP. Drying 
was carried out at -40°C for 3 – 4 days after separating 
each part of the shrimp shell (abdomen, head, and thorax). 
Dry shrimp shells were then mashed with a food processor 
for 2 – 3 minutes then sifted using a 60 mesh sieve. WSSP 
was stored in dark glass bottles coated with aluminum foil 
at 4°C. 19.20 The WSSP was added by suspending WSSP 
doses of 0.89gr/200gr/day and 1.77gr/200gr/day into 
Natrium Carboxymethylcellulose 0.5%. DPPH free radical 
scavenging and ABTs radical scavenging activity assays 
are used subjected to determine the antioxidant activity. 
WSSP and AST supplement in this study had IC50 
mentioned in Table 1.  
 
Chemicals 
 STZ (C8H15N3O7) and nicotinamide were obtained 
from Nacalai Tesque, Kyoto-Japan. Natrium 
Carboxymethyl Cellulose was obtained from Sigma-
Aldrich, Japan. TAC examination used the ABTs method 
with TAC kit obtained from Randox Laboratory, United 
Kingdom. Insulin examination using ELISA reagents was 
obtained from Wuhan-China, Fine test. Blood glucose 
examination reagents were obtained from Diasys-German 
and measurement of insulin resistance used the HOMA-IR 
method. 
 
Animals and Biological Material: 
 This study used 25 male white rats Wistar (Rattus 
novergicus) strain which was obtained from Central Food 
and Nutrition Laboratory, Gadjah Mada University-
Yogyakarta, Indonesia with inclusion criteria of male, age 




 STZ-NA, ELISA test for fasting insulin measurements, 
ABTs test for TAC examination. A microtube and 
centrifuge for 4000 rpm spinning.  
 
Laboratory Methods 
 The examination of the HOMA-IR and TAC levels was 
done twice which were three days after STZ-NA induction 
and at the end of the research. Before taking rats' blood, 
they have fasted for 8 – 10 hours. Two ml of blood from 
plexus retroorbitalis was taken and placed in a microtube 
then centrifuge and spin at 4000 rpm for 15 minutes. 
HOMA-IR index examination was obtained from fasting 
blood glucose levels and fasting blood insulin. Fasting 
glucose examination was performed by spectrophotometry 
and fasting insulin was measured by ELISA method in 
which TAC examination was carried out by ABTs method. 
 
Description of the Experiment 
 Sample preparation: Rats were acclimatized for seven 
days in individual stainless-steel cages at 21°C. It also had 
adequate air circulation and was exposed to light for 12 
hours. Feed type of Comfeed II with the composition of 
15% of crude protein, 3 – 7% of crude fat, 12% of 
moisture content, 6% of crude fiber, 7% of ash, 0.5% of 
phosphorus, and calcium 0.9 – 1.1% were given during the 
study. Rats in the K2 group received standard feed until 
the end of the study, while the remaining rats were induced 
to be T2DM by High-Fat Diet (HFD) followed by STZ-
NA. HFD was given from the second week to the third 
week. The feed composition of HFD used was a mixture of 
90% of Comfeed II, 10% of lard, and 1.25% of cholesterol 
of the total HFD feed weight. Comfeed II feed and HFD 
were given as much as 15 g/d. STZ-NA induction was 
carried out after rats received HFD for 14 days, STZ-NA 
dose was 45 mg/kg and 110 mg/kg (i.p). Rats induced by 
STZ-NA were declared to have T2DM if blood glucose 
levels were >250 mg/dl (Ghasemi, Khalifi and Jedi, 
2014). 
 Number of samples analyzed: 25 male white rats 
Wistar (Rattus novergicus) strain with the weight of 150-
200 grams, healthy and active. This research is a true 
experiment containing a randomized pre-posttest with a 
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control group design. Rats were split up into five groups of 
which each group consisted of five. K1 group was a group 
of T2DM rats, while K2 group was a group of healthy rats 
which did not receive any treatment. X1 and X2 groups 
were groups of T2DM rats treated with WSSP in doses of 
0.89 gr/200gr/d and 1.77gr/200gr/d respectively. Finally, 
X3 group was a group of T2DM rats treated with AST 
supplement in a dose of 0.09mg/200gr/d. WSSP and AST 
supplements were carried out for 21 days through the oral 
gavage. 
 Number of repeated analyses: 0 
 Number of experiment replication: 0 
 
Statistical Analysis 
 Statistical analysis was used to see the effect of giving 
WSSP and AST supplements on HOMA-IR and TAC 
levels. Paired t-test analysis was utilized to see 
dissimilarity of the HOMA-IR and TAC level before and 
after WSSP and AST supplement treatment in the data 
with normal distribution, whereas the Wilcoxon test was 
used to see differences of the HOMA-IR and TAC level 
before and after WSSP and AST supplement treatment in 
the data with the abnormal distribution. Analysis of 
HOMA-IR and TAC level between groups used the 
ANOVA test followed by the Poshoc Bonferoni test for 
the normally distributed data, otherwise, the Kruskal 
Wallis test was followed by Mann-Whitney test for the 
abnormally distributed data. Statistical analysis was done 
by using SPSS 21 software, the difference was significant 
when the p-value is less than 0.05 and CI of 95%. 
 
RESULTS AND DISCUSSION 
 The weighing of the rats was carried out every week 
upon which the average weight of the rat at the beginning 
of the study was 192.23 gr. The average weight and blood 
glucose of rats after the induction of HFD-STZ was 226.23 
gram and 420.03 mg/dl; hence, this indicates that the 
induction of HFD-STZ can increase the blood glucose 
levels and weight of the rats.  
 The effect of WSSP and AST supplement treatments on 
the TAC of rats induced by HFD-STZ can be seen in Table 
2. Both K2 and K1 groups had a reduced TAC level in the 
post-experiment and these differences were not significant 
(p = 0.180 and p = 0.063). All treatment groups (X1, X2, 
and X3) show increase TAC levels in the post-treatment, 
these were demonstrated by higher TAC levels in the post-
treatment than those of pre-treatment, and these were 
significantly different (p = 0.039, p = 0.001, and p = 
0.041).  These findings indicated that WSSP in doses used 
in this study were affiliated with the rise of TAC levels in 
T2DM rats, this association was also observed in AST 
treatment. 
 Because of Kruskal-Wallis test showed a significant 
difference of TAC level change (p <0.001, Table 2), the 
Mann-Whitney test was then performed and can be seen in 
Table 3. TAC level change of K2 compared with K1 
groups was not different (p = 0.408, Table 3). Both K2 and 
K1 groups were shown significant differences in TAC 
level change than each treatment group, i.e. X1, X2, and 
X3. The negative TAC level change in both control groups 
was significantly different than those of positive TAC 
level change in each treatment group (Table 2 and Table 
3). The TAC level change of X2 group was higher than X1 
group (ΔTACX2 = 0.86mmol/l ±0.19, p = 0.017) and this 
was notably contrast (p = 0.017 Table 3). This indicated 
that the dose of 1.77gr/200gr/d WSSP showed a better 
effect on TAC level change than the dose of 
0.89gr/200gr/d WSSP. The TAC level change of both X1 
and X2 groups was lower than X3 groups (Table 2). This 
indicated that the effect of WSSP on TAC level change 
was lower than AST in T2DM rats. There is a slight 
decrease in TAC in the group of K2 (-0.15 mmol / l) which 
is followed by an increase in blood glucose levels (p = 
0.007) and a decrease in insulin levels (p = 0.012) in Table 
4; therefore, this indicated that there is an association 
between the decrease of TAC level with T2DM. 
 There is a declining number in blood glucose levels and 
an inclining in insulin levels after the WSSP and AST 
supplement treatment in T2DM rats (p <0.05, Table 4). 
Both K2 and K1 groups had increase blood glucose levels 
in the post-experiment and this difference was significant 
(p = 0.007, p = 0.013, Table 4). K2 group has decreased 
blood insulin level in the post-experiment, and these 
differences were significant (p = 0.012, Table 4). 
 Because the Kruskall-Wallis test showed a significant 
difference in blood glucose and insulin change (p = 0.000, 
Table 4), the Mann-Whitney test was then performed 
(Table 5 and Table 6). Blood glucose level changes of K2 
and K1 groups were different (p = 0.009, Table 5). Both 
K2 and K1 groups were shown significantly different 
blood glucose level changes than each treatment group i.e. 
X1, X2, and X3. The blood glucose level change of X2 
group was higher than X1 group (Table 4), upon which 
this was significantly different (p = 0.009, Table 5). This 
indicates that the dose of 1.77gr/200gr/d WSSP showed a 
better effect on blood glucose level change than the dose 
of 0.89gr/200gr/d WSSP. The blood glucose level change 
of X2 group was higher than X3 group (Table 4), upon 
indicated that the effect of WSSP on blood glucose level 
change was better than AST supplement in T2DM rats. 
 The blood insulin level changes of K2 and K1 groups 
were different (p = 0.008, Table 6). Both K2 and K1 
groups were shown significantly different blood insulin 
level changes than each treatment group.  The blood 
insulin level change of X2 group was higher than X1 
group (Table 4), this indicated that the dose of 
1.77gr/200gr/d WSSP showed a better effect on blood 
insulin level change than the dose of 0.89gr/200gr/d 
WSSP. The blood insulin level change of X2 group was 
lower than X3 group (Table 4), this indicated that the 
effect of WSSP on blood insulin level change was lower 
than AST supplement. 
 The effect of WSSP and AST supplement treatment on 
the HOMA-IR of the T2DM rat is shown in Table 7. 
HOMA-IR index of K1 group was higher at the end of the 
experiment than those on the starting point and this was 
significantly different (p = 0.001, Table 7). Healthy rats in 
K-group showed no difference of HOMA-IR index in 
those to the final point (p = 0.235, Table 7). HOMA-IR 
index in each treatment group (X1, X2, and X3) was 
significantly lower in the post-treatment than in the pre-
treatment.  
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Table 1. IC50 Value of WSSP and AST Supplement using DPPH and ABTs Radical Scavenging. 
Method Sample IC50(ppm) 
DPPH WSSP 47,639.9 
AST Supplement 26,309.05 
ABTs WSSP 242,783 
AST Supplement 154,347.7 
 
 
Table 2. Effect of Whiteleg Shrimp Shell Powder and Astaxanthin Supplement on TAC (mmol/l) Level. 
Groups Pre-Treatment 
Mean ± SD 
Post-Treatment 




K2 2.06 (1.91 – 2.06) 1.91 ±0.18 -0.15 (0.15 – 0.15) 0.180b 0.000* 
K1 0.32 ±0.12 0.15 (0.15 – 0.29) -0.14 (0.01 – 0.15) 0.063b 
X1 0.29 ±0.15 0.74 (0.74-0.88) 0.59 (0.30 – 0.59) 0.039b* 
X2 0.44 (0.29 – 0.44) 1.24 ±0.17 0.86 ±0.19 0.001c* 
X3 0.26 ±0.12 1.91 (1.76 – 1.91) 1.61 (1.47 – 1.62) 0.041b* 
Note: K2 = healthy rat + standard feed; K1 = T2DM + standard feed; X1 = T2DM + WSSP 0.89 gr/200 gr/d; X2 = T2DM + 
WSSP 1.77 gr/200 gr/d; X3 = T2DM + AST supplement 0.09 mg/200 gr/d; data with normal distribution represented as 
mean ± SD, otherwise it was written as median (min-max); a =p value of the differences between pre- and post-treatment; b 
= Wilcoxon; c = paired t-test; d = p value for the differences between pre- and post-treatment among five groups (Kruskal 
Wallis); * = p value significant. 
 
Table 3. Mann Whitney Test of TAC Level Change (mmol/L) Pre-Post Treatment. 
Groups 
p value 
K2 K1 X1 X2 X3 
K2 - 0.408 0.006* 0.007* 0.007* 
K1  - 0.008* 0.008* 0.008* 
X1   - 0.017* 0.008* 
X2    - 0.008* 
X3     - 
  *p<0.05 = significant level 
 
 






Mean ± SD 
Post 
Mean ± SD 
Difference (Δ) pre-post 
treatment 
p value pc 
K2 Blood Glucose (mg/dl) 











K1 Blood Glucose (mg/dl) 











X1 Blood Glucose (mg/dl) 










X2 Blood Glucose (mg/dl) 










X3 Blood Glucose (mg/dl) 










Note: K2 = healthy rat + standard feed; K1 = T2DM + standard feed; X1 = T2DM + WSSP 0.89 gr/200 gr/d; X2 = T2DM + 
WSSP 1.77 gr/200gr/d; X3 = T2DM + AST supplement 0.09 mg/200 gr/d; data with normal distribution were represented as 
mean ± SD, otherwise it was written as median (min-max); a = paired t-test; b = Wilcoxon; c = p value for the difference 
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This indicated that WSSP and AST supplement 
treatments were reduced insulin resistance in T2DM rats. 
Additionally, T2DM rats without treatment showed an 
increase in insulin resistance at the end of treatment. There 
are differences in HOMA-IR among the groups after 
WSSP and AST supplements treatment (p = 0.000, Table 
7). The statistical analysis of the HOMA-IR index change 
was shown in Table 7. 
 The increase in HOMA-IR index change found in K1 
group was significantly different than those of a decrease 
in the HOMA-IR index change in the treatment group (X1, 
X2, and X3) (Table 7 and Table 8). This indicated that 
WSSP and AST supplement treatment was associated with 
reduced insulin resistance in T2DM rats. Decreasing the 
index in the HOMA-IR change of the X2 group was more 
obvious than those in X1 group, and this difference was 
significant (p = 0.016, Table 8). This suggested that WSSP 
Table 5. Mann Whitney Test of Blood Glucose Change Pre-Post Treatment.  
Groups 
p value 
K2 K1 X1 X2 X3 
K2 - 0.009* 0.009* 0.009* 0.009* 
K1  - 0.009* 0.009* 0.009* 
X1   - 0.009* 0.028* 
X2    - 0.175 
X3     - 
Note: *p<0.05 = significant level. 
 
Table 6. Mann Whitney Test of Blood Insulin Change Pre-Post Treatment. 
Groups p value K2 K1 X1 X2 X3 
K2 - 0.008* 0.009* 0.009* 0.009* 
K1  - 0.008* 0.008* 0.008* 
X1   - 0.009* 0.009* 
X2    - 0.009* 
X3     - 
Note: *p<0.05 = significant level. 
 
Table 7. Effect of Whiteleg Shrimp Shell Powder and AST Supplement on HOMA-IR Index. 
Groups Pre-Treatment 
Mean ± SD 
Post-Treatment 
Mean ± SD 
Difference (Δ) pre-post 
treatment 
pa pd 
K2 2.94 ±0.26 2.92 ±0.26 -0.03 ±0.04 0.235c 0.000* 
K1 11.77 ±0.66 12.21 ±0.63 0.45 ±0.12 0.001c* 
X1 10.97 ±0.36 4.26 ±0.08 -6.71 ±0.42 0.000c* 
X2 12.20 ±1.26 3.51 ±0.06 -9.41 (7.22,9.63) 0.043b* 
X3 10.98 ±0.73 3.35 ±0.08 -7.64 ±0.74 0.000c* 
Note: K2 = healthy rat + standard feed; K1 = T2DM + standard feed; X1 = T2DM + WSSP 0.89 gr/200 gr/d; X2 = 
T2DM + WSSP 1.77 gr/200 gr/d; X3 = T2DM + AST supplement 0.09 mg/200 gr/d; data with normal distribution were 
represented as mean ± SD, otherwise it was written as median (min-max); a = p value of the difference between pre and 
post treatment; b = Wilcoxon; c = paired t-test; d = p value for the difference between pre and post treatment among five 
groups (Kruskal Wallis); * = p value significant. 
 
Table 8. Mann Whitney Test of HOMA-IR Index Change Pre-Post Treatment . 
Groups 
p value 
K2 K1 X1 X2 X3 
K2 - 0.009* 0.009* 0.009* 0.009* 
K1  - 0.009* 0.009* 0.009* 
X1   - 0.016* 0.028* 
X2    - 0.175 
X3     - 
Note: *p <0.05 = significant level. 
Potravinarstvo Slovak Journal of Food Sciences 
Volume 15 708  2021 
in a dose of 1.77gr/200gr/d has a better effect on insulin 
resistance than the dose of 0.89gr/200gr/d on T2DM rats. 
Interestingly, decreasing HOMA-IR index change of X2 
group was not different than those of X3 group (p = 0.175, 
Table 8). This suggested that the dose of 1.77gr/200gr/d 
WSSP has no different than AST supplements in their 
ability to reduce insulin resistance.  
 The most interesting finding in this study was WSSP and 
AST had no different abilities in reducing insulin 
resistance in T2DM rats. This was shown by HOMA-IR 
index change analysis (Table 7 and Table 8). It was 
previously hypothesized that WSSP treatment has a higher 
ability than AST supplement in reducing insulin resistance. 
To our knowledge, this study was the first that shows this 
interesting finding. Previous studies open the possibility of 
many mechanisms involved in reducing insulin resistance. 
Although the results of the activity test of antioxidant 
WSSP was a low category, the bioactive component in 
WSSP will be digested by digestive enzymes including the 
pepsin and lipase enzyme in the body. This digestive 
process causes WSSP to be more representative when 
digested in the body. Pepsin is a hydrolase enzyme that 
catalyzes the hydrolysis reaction of a substrate using water 
molecules as a mediator. Pepsin can break down protein 
molecules to be smaller; therefore, the AST can separate 
itself from its bonds, in this case, are amino acids. In 
addition to the enzyme pepsin, the lipase enzyme, which is 
one of the enzymes that play a role in breaking down fat 
molecules into fatty acids, also plays a pivotal role in the 
release of AST from fatty acid bonds. The digestive 
process of AST follows the process of fat metabolism in 
the body. The absorption of AST greatly depends on the 
steps of food digestion to ease the absorption of AST into 
the intestinal lumen starting from the mechanical and 
chemical digestion of the digestive tract, emulsification 
assisted by bile salts, absorption by microvilli, and binding 
of AST with some lipoproteins. The emulsion of the fat 
types can increase the bioavailability of AST by expanding 
the surface for the release of AST. This emulsion’s works 
resemble the mechanism of release of bile salts during 
lipolysis and help the absorption of lipophilic compounds 
that will increase the solubility of AST. By formulating 
AST in the form of fat-based emulsions, AST absorption 
can get into the lymphatic circulation without having to 
follow fat metabolism from the beginning. Polar 
carotenoids such as zeaxanthin, lutein, AST are 
transported by High-Density Lipoprotein (HDL). The fat 
composition in WSSP and digestive processes in animal 
bodies can predictably increase AST bioavailability in 
WSSP, hence it can improve TAC and insulin resistance 
(Ayudiarti, 2011; Affandi, Julianto and Majeed, 2012; 
Ambati et al., 2014; Benarroch et al., 2016). 
 An increase in the production of ROS was accompanied 
by a decrease in TAC levels results in the release of fatty 
acids into the blood circulation. This mechanism impacts 
the activation of HIF-1 gene. The gene will have an impact 
on an increase in the activity of several enzymes such as 
JNK and IKK which are known to cause damage to insulin 
receptor cells in adipose tissue (Ye, 2013). Oxidative stress 
also results in insulin resistance in the liver and muscles by 
increasing Diasyl Glycerol (DAG) which increases Protein 
Kinase C (PKC), this is followed by a disruption of 
phosphorylation in Insulin Receptor Substrate (IRS-1 and 
IRS-2) as an indication of liver and muscle insulin 
resistance. An increase in fatty acids in the circulation due 
to oxidative stress also causes an increase in the formation 
of ceramide which will produce large amounts of Nitric 
Oxide (NO). This substance is toxic to pancreatic β cells 
and results in the death of pancreatic β cells which is 
known as T2DM (Al-Goblan, Al-Alfi and Khan, 2014; 
Sears and Perry, 2015).  
 Whiteleg Shrimp Shell Powder contains several bioactive 
components that can improve T2DM. One of the main 
antioxidants in the carotenoid category found in WSSP is 
AST, AST is known as a powerful antioxidant that works 
from inside and outside the cell (Ambati et al., 2014). 
Astaxanthin acts as a powerful antioxidant by the 
mechanism of supplying electrons and reacting with free 
radicals. One of which is ROS which will form more 
stable free radicals and stop the systemic reaction of free 
radicals. Astaxanthin can inhibit the production of ROS 
that occurs in mitochondria in antioxidant activity from 
AST. Therefore, it will increase antioxidant status in the 
bodies of rats induced by T2DM (Yang et al., 2015). The 
previous study shows that giving AST extract from shrimp 
waste increases the levels of Catalase (CAT), Superoxide 
Dismutase (SOD), and Glutathione Peroxide (GPx), 
particularly GPx in diabetic induced rats (Sila et al., 
2015). Astaxanthin supplements resulted in an increase in 
TAC in overweight and obese humans (Choi et al., 2011).  
Giving HFD-STZ aims to form oxidative stress in the body 
especially pancreatic β cells which are known as one of the 
cells of the body that contains a little antioxidant (Savu et 
al., 2012). Giving HFD-STZ results in a decrease in TAC 
levels which is caused by several things, namely an 
increase in the production of ROS and inadequate 
endogenous antioxidants due to competition between 
endogenous antioxidants and pro-oxidants in the body 
(Asmat, Abad and Ismail, 2016). There was a significant 
decrease in the levels GPx, Glutathione Redoxin (GR), and 
SOD when they were compared to the non DMT2 group 
(Aouacheri et al., 2015). A decrease in oxidative stress 
caused by the activity of AST antioxidant results in the 
improvement to insulin receptors which will lead to the 
improvement of the T2DM condition. There is a slight 
decrease in TAC in the group of K2 (-0.15 mmol / l) which 
is followed by an increase in blood glucose levels (p = 
0.007) and a decrease in insulin levels (p = 0.012). This 
condition was predictably caused by psychological stress 
experienced in K2 group. The lack of antioxidant 
composition in the standard feed also predictably leads to a 
decrease in TAC in the group of K2. It illustrates the 
importance of exogenous antioxidant intake to maintain 
body health (Shiloah et al., 2003).  
 The other study shows that there was a decrease in blood 
glucose levels in diabetic rats after the intake of AST with 
a dose of 50 mg/kg Body Weight and 100 mg/kg Body 
Weight for 14 days (Li et al., 2016). Shrimp waste oil can 
lower blood glucose levels in rats that were given HFD 
after glucose tolerance testing (Nair et al, 2017). The 
previous study shows that AST increases the production 
and secretion of insulin in T2DM rats. Regeneration of 
pancreatic β cells is caused by suppression of oxidative 
stress biomarkers such as H2O2 and MDA as well as an 
increase in total antioxidant capacity which results in a 
decrease in blood glucose levels in the circulation. 
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Therefore, it gives them time for β cells to repair to 
increase insulin secretion (Al-Bulish et al., 2017).  
 An increase in TAC resulted in an improvement in the 
HOMA-IR index. This research finds that there was an 
increase in TAC and a decrease in the HOMA-IR index 
after the treatment of WSSP and AST supplements. 
Astaxanthin is not the only bioactive substance contained 
in WSSP, chitosan is a chitin deacetylation product which 
is a polymer of glucosamine long-chain (β-1, 4-2 amino-2-
deoxy-D-glucose) which has an impact on the HOMA-IR 
index. Chitin and chitosan are known to have several 
activities such as antioxidants and antidiabetic. The 
mechanism of the improvement in T2DM done by chitosan 
through suppressing the process of gluconeogenesis in the 
liver is by suppressing the expression of 
Phosphoenolpiruvate Carboxykinase (PEPCK), p38 
phosphorylation, and an increase in the activities of  AMP-
kinase (AMPK) in the liver so that the store of glucose in 
the liver can be maintained. Chitosan also increases kinase 
Protein Akt / PKB which is the main mediator in the 
translocation of GLUT4. This can increase the uptake of 
glucose by expediting the translocation of GLUT4 from 
the circulation into glucose target tissues such as the liver 
and muscles (Liu, Chang and Chiang, 2010). The 
mechanism of T2DM repair done by chitosan provides an 
opportunity for Pancreatic β cells and insulin receptors to 
carry out cell regeneration due to a decrease in 
glucolipotoxicity and low calories from the standard feed. 
An increase in insulin secretion results in a decrease in 
blood glucose levels which leads to an improvement in the 
HOMA-IR index (Sathananthan et al., 2015).  
 Another component that contains WSSP is calcium 
which has a role in insulin secretion by pancreatic β cells. 
The condition of T2DM leads to a decrease in calcium 
levels both in extracellular and intracellular. Hypocalcemia 
was caused by the accumulation of Advanced Glycation 
End Products (AGEs) in bone collagen fibers. 
Accumulation of AGEs increases the process of calcium 
resorption that results in Osteoporosis under the condition 
of T2DM. As many as 85.49% of the calcium content in 
shrimp shells is known to be able to meet calcium needs to 
stimulate insulin secretion by pancreatic β cells when the 
condition of pancreatic β cells has improved and insulin 
secretion by β cells is still normal (Miyata et al., 1997). 
There was an increase in insulin secretion by pancreatic β 
after calcium supplementation for diabetic patients and 
those at risk of diabetes (Mitri et al., 2011). The other 
study shows that there was a decrease in the HOMA-IR 
index in diabetic patients that were given fortified yogurt 
of vitamin D and Calcium (Nikooyeh et al., 2011).  
 The results of this study showed that a higher increase of 
TAC was found in the treatment group of AST 
supplement, otherwise, the HOMA-IR index change 
showed that X2 group had better improvement compared 
to X1 and X3 treatment group. It indicated that WSSP has 
an advantage in improving the condition of T2DM. 
Bioactive substances contained in WSSP, such as AST, 
chitosan, and calcium, as well as various other substances, 
that get together with different mechanisms can reduce the 
HOMA-IR index as a form of improvement in T2DM 
conditions and insulin resistance in peripheral tissues. The 
results of this study provide a new insight into which 
WSSP can increase TAC and decrease the HOMA-IR 
index in T2DM conditions. Further researches need to be 
carried out to determine the in-depth mechanism for 
T2DM improvement by WSSP so it can make WSSP one 
of the products for prevention of T2DM disease and 
progressive prevention of T2DM itself. 
 
CONCLUSION 
 In a conclusion, the results of this study show a beneficial 
effect of WSSP in increasing TAC and decreasing the 
HOMA-IR index in Wistar rats induced by HFD-STZ. For 
further investigation of the proper use of pathohistological 
preview of the pancreatic tissue amelioration, it would be 
advisable to investigate the tissue remodeling and 
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